Micro-interventional dynamic outflow curve (miDOC) is a revolutionary technology developed by Professor Sean Ianchulev, from the New York Eye and Ear Infirmary (NYEE), USA.
While performing glaucoma procedures without miDOC, surgeons have no way of checking a patient’s exact ocular flow and pressure, a critical variable in the operating room. They can only check intraocular pressure before and after the procedure, which occasionally leaves unpredictable outcomes.
This has affected the precision of glaucoma surgery. Some surveys have reported more than 50 percent of the patients undergoing trabeculectomy and drainage device implants unable to achieve complete postoperative success and medication independence. In some cases, it is not until the follow-up appointment that ophthalmologists discover the procedure may not have worked and/or has possible complications.
miDOC allows eye surgeons to measure and respond to critical fluid dynamics inside the eye in real time – an advance that may significantly improve precision and outcomes in glaucoma and other ophthalmic procedures.
During surgery, miDOC enables continuous measurement of key parameters including:
- Pressure
- Flow
- Outflow facility
- Ocular rigidity/Compliance
These measurements provide new insight into how surgical interventions affect the eye in real time.
By providing real-time biometric feedback, miDOC has the potential to elevate glaucoma surgery to a new era of digital-guided precision.
NYEE is the only eye center in the US to use this technology and conduct the first-in-human clinical study. Surgeons started using it in patients in July 2025 and have completed the first 20 cases. According to investigators, all procedures were successfully completed with intra-operative biometric guidance.
Investigators at NYEE plan to further refine the technology and pursue regulatory pathways for broader clinical use.
No comments:
Post a Comment